Biogen Inc (NASDAQ:BIIB)’s traded shares stood at 0.82 million during the last session, with the company’s beta value hitting 0.13. At the close of trading,
In pre-hour trades, Biogen Inc. (BIIB) shares gained 45.61% to $288.00 after a surprise trial success. BIIB stock closed at $197.79, up just 1.04%. What
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne